Juno is led by a team of highly skilled experts, with decades of collective industry experience to drawn on, they offer a breadth of pharmaceutical knowledge. This knowledge paired with a genuine passion for innovation and to drive value consistently delivers superior outcomes for suppliers, customers and shareholders alike.

Ian Jacobson
Chief Executive Officer

Ian has over 35 years of pharmaceutical industry experience. Prior to founding Juno, Ian worked for Arrow Pharmaceuticals as the CEO of Cobalt Pharmaceuticals from 2000 – 2010, he was also instrumental in the development of Arrow’s other international business units. As CEO of Cobalt, Ian was responsible for managing over $300 million in annual sales and played a key role in facilitating the sale of Arrow to Watson Pharmaceuticals (now Actavis) in June 2009 for over $2.4 billion USD. Prior to his work at Arrow, Ian was an executive at Par Pharmaceuticals (US) in the Office of the President, Gingham Canada as Executive Vice President and Amerpharm/Merck KGaA as a Senior Executive in the international generics business.

Read more

Craig Podolsky
President

Craig has over 15 years of pharmaceutical industry experience. Prior to co-founding Juno in 2011, Craig worked for Cobalt Pharmaceuticals in its business development group. He was responsible for negotiating product license and supply agreements for Cobalt’s OTC and generic divisions, and was Cobalt’s primary lead on all global M&A transactions.

Read more

Mark Roberts
Chief Operating Officer

Mark has worked in global pharmaceutical markets for over 20 years. Before joining Juno, Mark worked at Zydus Cadila as VP Global Licensing (2009 – 2011) where he was responsible for establishing a global licensing business unit focused on generics, bio-generics and branded products. Prior to his work at Zydus, Mark oversaw the set up and management of a new global licensing business unit at Pliva (division of Barr Labs, eventually acquired by Teva), where he had full responsibility for the establishment and expansion of Pliva’s licensing activities and strategic alliances in Europe, South Africa, Asia Pacific and North America. He also formerly worked for the Helm group from 1997-2003, where he ran pharmaceutical licensing and distribution for South Africa and the USA.

Read more

Chris Ichiyen, CPA, CA
Vice President of Finance

Chris has over 14 years of pharmaceutical industry experience, most recently having worked for a regulatory consulting company as their Vice President of Finance in the burgeoning Canadian Cannabis industry from 2018 to 2019. Prior to this he worked as a senior member of the management team for the Canadian Finance Country Head with Actavis Pharma as a member of the senior management team. Experienced in mergers and acquisition and post acquisition integration including in-depth support on $1.8 billion of transactions. Prior to this Chris worked as an Audit Manager for KPMG.

Read more

Andrew Brown
Head of Intellectual Property

Andrew Brown is a Chartered UK and European Patent Attorney with over 20 years of pharmaceutical industry experience. Before joining Juno in 2016, Andrew served as the Head of IP at Pharmathen, and prior to that he served in a number of high profile IP roles at various leading pharmaceutical companies, including Senior Patent Attorney at AstraZeneca and IP Director at Teva.

Read more

Jesse Buckstein
Director of Corporate Development

Jesse joined Juno in 2014 and has over 10 years of corporate finance and pharmaceutical experience. Prior to joining Juno, Jesse was a senior corporate banking analyst at TD. He also obtained considerable private and public asset management experience through his work with Tandem Expansion Fund and GMP Investment Management.

Read more

CVS Murthy
General Manager India

CVS Murthy has over 20 years of pharmaceutical industry experience. He is responsible for managing Juno’s product sourcing and distribution from Asian suppliers and generally supporting Juno’s business development activities with its global partners. Prior to joining Juno, Murthy served as General Manager – Indian Operations for Arrow Pharmaceuticals. He also has experience serving in a range of business development roles for several leading Indian pharmaceutical companies, including Dr. Reddy’s and Alembic.

Read more

Lewis King
Licensing & Business Development Manager

Lewis started working in the pharmaceutical industry in 2014, gaining experience in medicine and medical device regulatory affairs. Previously Lewis researched novel drug pharmacodynamics in cell biology at the University of Nevada, Reno and Queen’s University Belfast. Lewis joined Juno’s Business Development team in 2019, and is responsible for global business development and licensing activities including identifying strategic opportunities, contract negotiation, valuation and business analysis.

Read more